Prospective risk stratification of sudden cardiac death in Marfan's syndrome.

Hoffmann, Boris A; Rybczynski, Meike; Rostock, Thomas; Servatius, Helge Simon; Drewitz, Imke; Steven, Daniel; Aydin, Ali; Sheikhzadeh, Sara; Darko, Vivien; von Kodolitsch, Yskert; Willems, Stephan (2013). Prospective risk stratification of sudden cardiac death in Marfan's syndrome. International journal of cardiology, 167(6), pp. 2539-45. Elsevier 10.1016/j.ijcard.2012.06.036

Full text not available from this repository. (Request a copy)

BACKGROUND

Marfan syndrome (MFS) is a variable, autosomal-dominant disorder of the connective tissue. In MFS serious ventricular arrhythmias and sudden cardiac death (SCD) can occur. The aim of this prospective study was to reveal underlying risk factors and to prospectively investigate the association between MFS and SCD in a long-term follow-up.

METHODS

77 patients with MFS were included. At baseline serum N-terminal pro-brain natriuretic peptide (NT-proBNP), transthoracic echocardiogram, 12-lead resting ECG, signal-averaged ECG (SAECG) and a 24-h Holter ECG with time- and frequency domain analyses were performed. The primary composite endpoint was defined as SCD, ventricular tachycardia (VT), ventricular fibrillation (VF) or arrhythmogenic syncope.

RESULTS

The median follow-up (FU) time was 868 days. Among all risk stratification parameters, NT-proBNP remained the exclusive predictor (hazard ratio [HR]: 2.34, 95% confidence interval [CI]: 1.1 to 4.62, p=0.01) for the composite endpoint. With an optimal cut-off point at 214.3 pg/ml NT-proBNP predicted the composite primary endpoint accurately (AUC 0.936, p=0.00046, sensitivity 100%, specificity 79.0%). During FU, seven patients of Group 2 (NT-proBNP ≥ 214.3 pg/ml) reached the composite endpoint and 2 of these patients died due to SCD. In five patients, sustained VT was documented. All patients with a NT-proBNP<214.3 pg/ml (Group 1) experienced no events. Group 2 patients had a significantly higher risk of experiencing the composite endpoint (logrank-test, p<0.001).

CONCLUSIONS

In contrast to non-invasive electrocardiographic parameter, NT-proBNP independently predicts adverse arrhythmogenic events in patients with MFS.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
UniBE Contributor:	Servatius, Helge Simon (A)
Subjects:	600 Technology > 610 Medicine & health
ISSN:	0167-5273
Publisher:	Elsevier
Language:	English
Submitter:	Helge Simon Servatius
Date Deposited:	24 Feb 2014 10:36
Last Modified:	29 Mar 2023 23:33
Publisher DOI:	10.1016/j.ijcard.2012.06.036
PubMed ID:	22738784
Uncontrolled Keywords:	Cardiomyopathy, Marfan syndrome, Natriuretic peptide, Sudden cardiac death, Ventricular arrhythmia
URI:	https://boris.unibe.ch/id/eprint/42347